FZMD - Fuse Medical, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.5500
0.0000 (0.00%)
At close: 10:43AM EDT
Stock chart is not supported by your current browser
Previous Close0.5500
Open0.5500
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.5500 - 0.5500
52 Week Range0.3000 - 0.7500
Volume1
Avg. Volume201
Market Cap41.03M
Beta (3Y Monthly)3.37
PE Ratio (TTM)6.79
EPS (TTM)0.0810
Earnings DateMay 8, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Business Wire

    Fuse Medical, Inc. Ranked Among Top 150 Public Companies in Dallas- Fort Worth Metroplex

    Fuse Medical, Inc., (FZMD), an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced that it has been ranked number 137 on the 2019 list of Dallas-Fort Worth’s 150 largest public companies, by the Dallas Morning News. Fuse Medical’s 2018 revenue of $26.4 million secured its title as the 137th largest public company in DFW, moving them up six spots from where they ranked last year. The annual list, compiled by Bloomberg for the Dallas Morning News, examines public companies in a seven-county area in North Texas, and ranks them by their total revenue for the prior fiscal year.

  • Business Wire

    Fuse Medical Announces Launch of Suture Anchor Product Line for Sports Medicine

    Fuse Medical, Inc., (FZMD), an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced their latest addition of orthopedic and sports medicine product offerings, the Galen Medial and Galen XT Suture Anchors, the Kopis Knotless Anchor, and the Vida Interference Screws. The Fuse Suture Anchors are manufactured in the United States from PEEK and Titanium materials and are intended for use in the fixation of ligament, tendon, bone, or soft tissue to bone in knee, shoulder, foot/ankle, elbow, and hand/wrist procedures. The Fuse Suture Anchors are available sterile, loaded on individual inserters, and with or without integrated sutures and or needles.

  • Business Wire

    Fuse Medical Announces Launch of Sterizo Total Knee Replacement System

    Fuse Medical, Inc., , an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced the launch of the Sterizo Total Knee Replacement System, the latest addition to a comprehensive line of orthopedic product offerings.

  • Business Wire

    Fuse Medical Reports Second Quarter 2019 Results

    Fuse Medical, Inc., (FZMD), emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced that it has filed its quarterly report on Form 10-Q for the second quarter ended June 30, 2019, with the United States Securities and Exchange Commission, on Monday, August 12, 2019. Christopher C. Reeg, Chief Executive Officer, commented, “We are pleased to announce improvements in our second quarter of 2019 results, with a twenty two (22) percentage point increase to gross profit and twenty five (25) percentage point improvement in earnings, as a percentage of net revenues, compared to the same period one year ago. The filing can be found on the Company’s website at http://www.fusemedical.com/investors.

  • Business Wire

    Fuse Medical Announces 2019 Annual Shareholder Meeting Results

    Fuse Medical, Inc., (FZMD), an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced the results of its 2019 Annual Shareholder Meeting that was held on Wednesday, June 26, 2019. Election of Directors: All five directors named in the proxy statement were re-elected to serve on the Company’s Board of Directors: Mark W. Brooks, Christopher C. Reeg, William E. McLaughlin, III, Renato V. Bosita Jr., MD and Ricky Raj S. Kalra, MD. Christopher C. Reeg, Chief Executive Officer, commented, “We are pleased the shareholders of Fuse have shown their confidence with the Executive team by electing them to serve as Directors for another year.

  • Business Wire

    Fuse Medical Reports First Quarter 2019 Results

    Fuse Medical, Inc., (FZMD), a distributor and an emerging manufacturer of medical devices for the orthopedic and spine marketplace, announced that it has filed its quarterly report on Form 10-Q for the first quarter ended March 31, 2019, with the United States Securities and Exchange Commission, on Tuesday, May 7, 2019. Christopher C. Reeg, Chief Executive Officer, commented, “We are pleased to announce improvements in our first quarter of 2019 results, with an eleven (11) percentage point increase to gross profit and one (1) percentage point improvement in earnings, as a percentage of net revenues, compared to the same period one year ago. The filing can be found on the Company’s website at http://www.fusemedical.com/investors.

  • Business Wire

    Fuse Medical Reports Full Year 2018 Financial Results with Record Earnings

    Fuse Medical, Inc., , an emerging manufacturer and distributor of medical devices for the orthopedic and spine marketplace, announced record earnings for the fiscal year ended December 31, 2018.

  • Business Wire

    OTC Markets Lists Securities of Fuse Medical, Inc. as Exempt from Penny Stock Designation

    Fuse Medical, Inc., , , announced that OTC Markets has identified Fuse as “Penny Stock Exempt,” meaning that shares of Fuse’s common stock, par value $0.01 per share , is no longer a “Penny Stock” as defined in Rule 3a51-1, promulgated under the Securities Exchange Act of 1934, as amended.

  • Business Wire

    Fuse Medical, Inc. Ranked No. 56 Fastest Growing Company in North America on Deloitte’s 2018 Technology Fast 500TM

    Fuse Medical, Inc., , , a contract manufacturer and national distributor of medical devices, announced that it has been named Number 56 on the Deloitte’s 2018 Technology Fast 500TM , an annual ranking of the fastest growing North American companies in the technology, media, telecommunications, life sciences and energy tech sectors.

  • Business Wire

    Fuse Medical, Inc. Files Quarterly Report on Form 10-Q

    Fuse Medical, Inc., , , announced that it has filed its quarterly report on Form 10-Q for the third quarter ended September 30, 2018 of the Fiscal Year 2018 with the United States Securities and Exchange Commission, on Tuesday November 13, 2018.